About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01735032

Multimodal Imaging in Pre-surgical Evaluation of Epilepsy

Epilepsy is the most common chronic neurological disorder in the world, affecting more than 50 million people worldwide. Approximately 35% of patients with epilepsy are refractory to all available ant...

Lead sponsor: Hospices Civils de Lyon•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Julien Jung, Dr.

CONTACT

0033 472 117 833 julien.jung@chu-lyon.fr

Sponsors

Lead Sponsor

Hospices Civils de Lyon

The purpose of this study is (i) to evaluate rigorously the diagnostic value of multimodal imaging for non-invasive localization of the EZ and (ii) to better target the indications for intracerebral recordings (SEEG).

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patient with drug-resistant focal epilepsy
•Candidates for pre-surgical evaluation including FDG PET, MRI, MEG and SEEG recordings.
•Age 18-65 years
•EEG-confirmed focal epilepsy for \>2 years
•Signed informed consent form.

Exclusion Criteria

•Age \<18 years and \>65 years
•Contraindication to the MRI
•Pregnant woman
•Head size incompatible with MEG recordings
•Adult subject to legal protection measure.

Related studies

Surgery as a Treatment for Medically Intractable Epilepsy

NCT01273129 · Epilepsy, Epilepsy, Temporal Lobe, and more

Active Not RecruitingPhase 3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 · Partial Epilepsy

COMPLETEDPhase 1

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314 · Partial Epilepsy

COMPLETEDPhase 2

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

NCT00465517 · Partial Epilepsy, Catamenial Epilepsy

COMPLETEDPhase 3

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy

NCT02076698 · Partial Epilepsy, Surgery

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 30, 2012Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment140

Start dateOct 2012

Last updatedNov 30, 2012

Condition

Partial Epilepsy

Locations shown

Hospices Civils de Lyon

Lyon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 30, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions